HEADER TRANSFERASE 29-AUG-14 4WAG TITLE PHOSPHATIDYLINOSITOL 4-KINASE III BETA CRYSTALLIZED WITH MI103 TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHOSPHATIDYLINOSITOL 4-KINASE BETA,PHOSPHATIDYLINOSITOL 4- COMPND 3 KINASE BETA; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: UNP RESIDUES 128-422, UNP RESIDUES 523-799; COMPND 6 SYNONYM: PTDINS 4-KINASE BETA,NPIK,PI4K92,PTDINS 4-KINASE BETA,NPIK, COMPND 7 PI4K92; COMPND 8 EC: 2.7.1.67; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PI4KB, PIK4CB; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR D.CHALUPSKA,E.BOURA REVDAT 3 06-SEP-17 4WAG 1 REMARK REVDAT 2 27-MAY-15 4WAG 1 JRNL REVDAT 1 20-MAY-15 4WAG 0 JRNL AUTH I.MEJDROVA,D.CHALUPSKA,M.KOGLER,M.SALA,P.PLACKOVA, JRNL AUTH 2 A.BAUMLOVA,H.HREBABECKY,E.PROCHAZKOVA,M.DEJMEK,R.GUILLON, JRNL AUTH 3 D.STRUNIN,J.WEBER,G.LEE,G.BIRKUS,H.MERTLIKOVA-KAISEROVA, JRNL AUTH 4 E.BOURA,R.NENCKA JRNL TITL HIGHLY SELECTIVE PHOSPHATIDYLINOSITOL 4-KINASE III BETA JRNL TITL 2 INHIBITORS AND STRUCTURAL INSIGHT INTO THEIR MODE OF ACTION. JRNL REF J.MED.CHEM. V. 58 3767 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 25897704 JRNL DOI 10.1021/ACS.JMEDCHEM.5B00499 REMARK 2 REMARK 2 RESOLUTION. 3.41 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8_1069) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.41 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.14 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 8934 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.212 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 447 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 49.1464 - 4.9133 1.00 2897 153 0.1975 0.2114 REMARK 3 2 4.9133 - 3.9003 1.00 2802 147 0.1917 0.2541 REMARK 3 3 3.9003 - 3.4074 0.99 2788 147 0.2551 0.3056 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.000 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.240 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.013 3790 REMARK 3 ANGLE : 1.145 5128 REMARK 3 CHIRALITY : 0.077 573 REMARK 3 PLANARITY : 0.005 654 REMARK 3 DIHEDRAL : 14.917 1407 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4WAG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 01-SEP-14. REMARK 100 THE DEPOSITION ID IS D_1000203470. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-JUL-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.918417 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8935 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.407 REMARK 200 RESOLUTION RANGE LOW (A) : 49.140 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 7.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.8100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.48 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% W/V PEG 4000, 20% V/V GLYCEROL 0.1 REMARK 280 M MOPS/HEPES-NA PH 7.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+3/4 REMARK 290 4555 Y,-X,Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 27.56900 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 41.35350 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 13.78450 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21290 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 128 REMARK 465 TRP A 129 REMARK 465 HIS A 224 REMARK 465 ILE A 225 REMARK 465 SER A 226 REMARK 465 THR A 227 REMARK 465 GLN A 228 REMARK 465 ARG A 229 REMARK 465 HIS A 230 REMARK 465 SER A 231 REMARK 465 ARG A 232 REMARK 465 GLY A 233 REMARK 465 THR A 234 REMARK 465 LYS A 235 REMARK 465 LEU A 236 REMARK 465 ARG A 237 REMARK 465 LYS A 238 REMARK 465 LEU A 239 REMARK 465 ILE A 240 REMARK 465 LEU A 241 REMARK 465 SER A 242 REMARK 465 ASP A 243 REMARK 465 GLU A 244 REMARK 465 LEU A 245 REMARK 465 LYS A 246 REMARK 465 PRO A 247 REMARK 465 ALA A 248 REMARK 465 HIS A 249 REMARK 465 ARG A 250 REMARK 465 LYS A 251 REMARK 465 ARG A 252 REMARK 465 GLU A 253 REMARK 465 LEU A 254 REMARK 465 PRO A 255 REMARK 465 SER A 256 REMARK 465 LEU A 257 REMARK 465 SER A 258 REMARK 465 PRO A 259 REMARK 465 ALA A 260 REMARK 465 PRO A 261 REMARK 465 ASP A 262 REMARK 465 THR A 263 REMARK 465 GLY A 264 REMARK 465 LEU A 265 REMARK 465 SER A 266 REMARK 465 PRO A 267 REMARK 465 SER A 268 REMARK 465 LYS A 269 REMARK 465 ARG A 270 REMARK 465 THR A 271 REMARK 465 HIS A 272 REMARK 465 GLN A 273 REMARK 465 ARG A 274 REMARK 465 SER A 275 REMARK 465 LYS A 276 REMARK 465 SER A 277 REMARK 465 ASP A 278 REMARK 465 ALA A 279 REMARK 465 THR A 280 REMARK 465 ALA A 281 REMARK 465 SER A 282 REMARK 465 ILE A 283 REMARK 465 SER A 284 REMARK 465 LEU A 285 REMARK 465 SER A 286 REMARK 465 SER A 287 REMARK 465 ASN A 288 REMARK 465 LEU A 289 REMARK 465 LYS A 290 REMARK 465 ARG A 291 REMARK 465 THR A 292 REMARK 465 ALA A 293 REMARK 465 SER A 294 REMARK 465 ASN A 295 REMARK 465 PRO A 296 REMARK 465 LYS A 297 REMARK 465 VAL A 298 REMARK 465 GLU A 299 REMARK 465 ASN A 300 REMARK 465 GLU A 301 REMARK 465 ASP A 302 REMARK 465 GLU A 303 REMARK 465 GLU A 304 REMARK 465 LEU A 305 REMARK 465 SER A 306 REMARK 465 SER A 307 REMARK 465 SER A 308 REMARK 465 THR A 309 REMARK 465 GLU A 310 REMARK 465 SER A 311 REMARK 465 ILE A 312 REMARK 465 ASP A 313 REMARK 465 ASN A 314 REMARK 465 ASN A 521 REMARK 465 ARG A 522 REMARK 465 ARG A 523 REMARK 465 ASP A 524 REMARK 465 PRO A 525 REMARK 465 GLU A 526 REMARK 465 ASP A 527 REMARK 465 PRO A 528 REMARK 465 SER A 529 REMARK 465 ALA A 530 REMARK 465 VAL A 531 REMARK 465 ALA A 532 REMARK 465 LEU A 533 REMARK 465 LYS A 534 REMARK 465 GLU A 535 REMARK 465 PRO A 536 REMARK 465 SER A 799 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 132 NE CZ NH1 NH2 REMARK 470 LYS A 137 CG CD CE NZ REMARK 470 LEU A 138 CG CD1 CD2 REMARK 470 LYS A 152 CG CD CE NZ REMARK 470 MET A 223 CG SD CE REMARK 470 TRP A 537 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 537 CZ3 CH2 REMARK 470 PHE A 703 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU A 704 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU A 572 OH TYR A 598 2.05 REMARK 500 NZ LYS A 348 O LYS A 392 2.08 REMARK 500 O SER A 640 OG1 THR A 643 2.19 REMARK 500 O ASP A 671 ND2 ASN A 676 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 132 -123.51 48.19 REMARK 500 LEU A 138 -81.28 -106.10 REMARK 500 ASP A 222 -1.27 67.74 REMARK 500 SER A 317 -0.46 69.42 REMARK 500 ALA A 365 -167.85 -163.93 REMARK 500 PRO A 382 77.04 -66.13 REMARK 500 ASN A 615 -5.89 66.42 REMARK 500 ILE A 619 -20.07 71.54 REMARK 500 LEU A 694 -117.00 55.19 REMARK 500 ASN A 700 -117.75 56.23 REMARK 500 HIS A 777 71.64 51.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 3K7 A 801 DBREF 4WAG A 128 522 UNP Q9UBF8 PI4KB_HUMAN 128 422 DBREF 4WAG A 523 799 UNP Q9UBF8 PI4KB_HUMAN 523 799 SEQRES 1 A 572 SER TRP LEU LEU ARG LEU PHE GLU SER LYS LEU PHE ASP SEQRES 2 A 572 ILE SER MET ALA ILE SER TYR LEU TYR ASN SER LYS GLU SEQRES 3 A 572 PRO GLY VAL GLN ALA TYR ILE GLY ASN ARG LEU PHE CYS SEQRES 4 A 572 PHE ARG ASN GLU ASP VAL ASP PHE TYR LEU PRO GLN LEU SEQRES 5 A 572 LEU ASN MET TYR ILE HIS MET ASP GLU ASP VAL GLY ASP SEQRES 6 A 572 ALA ILE LYS PRO TYR ILE VAL HIS ARG CYS ARG GLN SER SEQRES 7 A 572 ILE ASN PHE SER LEU GLN CYS ALA LEU LEU LEU GLY ALA SEQRES 8 A 572 TYR SER SER ASP MET HIS ILE SER THR GLN ARG HIS SER SEQRES 9 A 572 ARG GLY THR LYS LEU ARG LYS LEU ILE LEU SER ASP GLU SEQRES 10 A 572 LEU LYS PRO ALA HIS ARG LYS ARG GLU LEU PRO SER LEU SEQRES 11 A 572 SER PRO ALA PRO ASP THR GLY LEU SER PRO SER LYS ARG SEQRES 12 A 572 THR HIS GLN ARG SER LYS SER ASP ALA THR ALA SER ILE SEQRES 13 A 572 SER LEU SER SER ASN LEU LYS ARG THR ALA SER ASN PRO SEQRES 14 A 572 LYS VAL GLU ASN GLU ASP GLU GLU LEU SER SER SER THR SEQRES 15 A 572 GLU SER ILE ASP ASN SER PHE SER SER PRO VAL ARG LEU SEQRES 16 A 572 ALA PRO GLU ARG GLU PHE ILE LYS SER LEU MET ALA ILE SEQRES 17 A 572 GLY LYS ARG LEU ALA THR LEU PRO THR LYS GLU GLN LYS SEQRES 18 A 572 THR GLN ARG LEU ILE SER GLU LEU SER LEU LEU ASN HIS SEQRES 19 A 572 LYS LEU PRO ALA ARG VAL TRP LEU PRO THR ALA GLY PHE SEQRES 20 A 572 ASP HIS HIS VAL VAL ARG VAL PRO HIS THR GLN ALA VAL SEQRES 21 A 572 VAL LEU ASN SER LYS ASP LYS ALA PRO TYR LEU ILE TYR SEQRES 22 A 572 VAL GLU VAL LEU GLU CYS GLU ASN PHE ASP THR THR SER SEQRES 23 A 572 VAL PRO ALA ARG ILE PRO GLU ASN ARG ARG ASP PRO GLU SEQRES 24 A 572 ASP PRO SER ALA VAL ALA LEU LYS GLU PRO TRP GLN GLU SEQRES 25 A 572 LYS VAL ARG ARG ILE ARG GLU GLY SER PRO TYR GLY HIS SEQRES 26 A 572 LEU PRO ASN TRP ARG LEU LEU SER VAL ILE VAL LYS CYS SEQRES 27 A 572 GLY ASP ASP LEU ARG GLN GLU LEU LEU ALA PHE GLN VAL SEQRES 28 A 572 LEU LYS GLN LEU GLN SER ILE TRP GLU GLN GLU ARG VAL SEQRES 29 A 572 PRO LEU TRP ILE LYS PRO TYR LYS ILE LEU VAL ILE SER SEQRES 30 A 572 ALA ASP SER GLY MET ILE GLU PRO VAL VAL ASN ALA VAL SEQRES 31 A 572 SER ILE HIS GLN VAL LYS LYS GLN SER GLN LEU SER LEU SEQRES 32 A 572 LEU ASP TYR PHE LEU GLN GLU HIS GLY SER TYR THR THR SEQRES 33 A 572 GLU ALA PHE LEU SER ALA GLN ARG ASN PHE VAL GLN SER SEQRES 34 A 572 CYS ALA GLY TYR CYS LEU VAL CYS TYR LEU LEU GLN VAL SEQRES 35 A 572 LYS ASP ARG HIS ASN GLY ASN ILE LEU LEU ASP ALA GLU SEQRES 36 A 572 GLY HIS ILE ILE HIS ILE ASP PHE GLY PHE ILE LEU SER SEQRES 37 A 572 SER SER PRO ARG ASN LEU GLY PHE GLU THR SER ALA PHE SEQRES 38 A 572 LYS LEU THR THR GLU PHE VAL ASP VAL MET GLY GLY LEU SEQRES 39 A 572 ASP GLY ASP MET PHE ASN TYR TYR LYS MET LEU MET LEU SEQRES 40 A 572 GLN GLY LEU ILE ALA ALA ARG LYS HIS MET ASP LYS VAL SEQRES 41 A 572 VAL GLN ILE VAL GLU ILE MET GLN GLN GLY SER GLN LEU SEQRES 42 A 572 PRO CYS PHE HIS GLY SER SER THR ILE ARG ASN LEU LYS SEQRES 43 A 572 GLU ARG PHE HIS MET SER MET THR GLU GLU GLN LEU GLN SEQRES 44 A 572 LEU LEU VAL GLU GLN MET VAL ASP GLY SER MET ARG SER HET 3K7 A 801 22 HETNAM 3K7 6-CHLORO-3-(3,4-DIMETHOXYPHENYL)-2-METHYLIMIDAZO[1,2- HETNAM 2 3K7 B]PYRIDAZIN-8-AMINE FORMUL 2 3K7 C15 H15 CL N4 O2 HELIX 1 AA1 ASP A 140 SER A 151 1 12 HELIX 2 AA2 GLY A 155 LEU A 164 1 10 HELIX 3 AA3 PHE A 165 PHE A 167 5 3 HELIX 4 AA4 ARG A 168 ASP A 173 1 6 HELIX 5 AA5 TYR A 175 MET A 186 1 12 HELIX 6 AA6 ASP A 187 SER A 205 1 19 HELIX 7 AA7 SER A 205 TYR A 219 1 15 HELIX 8 AA8 LEU A 322 ARG A 338 1 17 HELIX 9 AA9 LEU A 339 LEU A 342 5 4 HELIX 10 AB1 THR A 344 SER A 357 1 14 HELIX 11 AB2 LEU A 358 LYS A 362 5 5 HELIX 12 AB3 PRO A 382 ALA A 386 5 5 HELIX 13 AB4 GLU A 539 GLU A 546 1 8 HELIX 14 AB5 SER A 548 LEU A 553 5 6 HELIX 15 AB6 LEU A 569 GLU A 589 1 21 HELIX 16 AB7 ILE A 619 GLN A 627 1 9 HELIX 17 AB8 SER A 629 HIS A 638 1 10 HELIX 18 AB9 THR A 643 LEU A 667 1 25 HELIX 19 AC1 HIS A 673 GLY A 675 5 3 HELIX 20 AC2 THR A 711 GLY A 719 1 9 HELIX 21 AC3 MET A 725 GLN A 755 1 31 HELIX 22 AC4 SER A 766 HIS A 777 1 12 HELIX 23 AC5 THR A 781 MET A 797 1 17 SHEET 1 AA1 3 HIS A 376 ARG A 380 0 SHEET 2 AA1 3 TYR A 397 GLU A 405 -1 O GLU A 402 N ARG A 380 SHEET 3 AA1 3 VAL A 387 VAL A 388 -1 N VAL A 387 O LEU A 398 SHEET 1 AA2 5 HIS A 376 ARG A 380 0 SHEET 2 AA2 5 TYR A 397 GLU A 405 -1 O GLU A 402 N ARG A 380 SHEET 3 AA2 5 TRP A 556 LYS A 564 -1 O ARG A 557 N VAL A 403 SHEET 4 AA2 5 GLY A 608 ILE A 610 -1 O ILE A 610 N ILE A 562 SHEET 5 AA2 5 ILE A 600 LEU A 601 -1 N LEU A 601 O MET A 609 SHEET 1 AA3 2 ILE A 677 LEU A 679 0 SHEET 2 AA3 2 ILE A 685 HIS A 687 -1 O ILE A 686 N LEU A 678 CISPEP 1 LEU A 138 PHE A 139 0 -2.84 CISPEP 2 LEU A 363 PRO A 364 0 -2.54 SITE 1 AC1 10 ILE A 562 LYS A 564 GLU A 572 TYR A 598 SITE 2 AC1 10 ILE A 610 GLU A 611 PRO A 612 VAL A 613 SITE 3 AC1 10 LEU A 678 ASP A 689 CRYST1 108.353 108.353 55.138 90.00 90.00 90.00 P 43 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009229 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009229 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018136 0.00000